KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Resmed (RMD) Cost of Revenue (2016 - 2025)

Resmed's Cost of Revenue history spans 17 years, with the latest figure at $544.1 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 4.0% year-over-year to $544.1 million; the TTM value through Dec 2025 reached $2.1 billion, up 6.68%, while the annual FY2025 figure was $2.1 billion, 4.72% up from the prior year.
  • Cost of Revenue reached $544.1 million in Q4 2025 per RMD's latest filing, up from $506.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $550.7 million in Q2 2025 to a low of $321.5 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $456.6 million, with a median of $492.1 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: decreased 5.11% in 2021, then surged 40.75% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $390.6 million in 2021, then grew by 14.38% to $446.7 million in 2022, then grew by 15.48% to $515.9 million in 2023, then increased by 1.42% to $523.2 million in 2024, then grew by 4.0% to $544.1 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Cost of Revenue are $544.1 million (Q4 2025), $506.9 million (Q3 2025), and $550.7 million (Q2 2025).